Day 1: Next Generation Vaccines: Adjuvants and delivery systems
This session will discuss current research into the development of new or enhanced adjuvants and novel delivery systems which are widely accepted as key to creating more efficacious vaccines with improved methods for storage and delivery. Session Chair: To be confirmed
- Morning Poster Session: Vaccine Adjuvants
- Afternoon Poster Session: Vaccine Delivery Systems
Day 2: Advances in overcoming co-infections
The advent of effective combination antiretroviral therapy has made living with, rather than dying from HIV-1 infection a reality. Now, an ageing HIV-1 seropositive population are living with co-infection by pathogens for which effective treatments remain in development. As the effort to develop prophylactic or therapeutic vaccines continue, the aim of this session will highlight advances in the science of pathogens commonly found as co-infections in people living with HIV. Session Chair: Christopher JK Ward
, Innate Immune Sensors Group Institute of Infection & Immunity Cardiff University School of Medicine
- Morning Poster Session: Research in overcoming co -infections
- Afternoon Poster Session: Open poster session.
Day 3: The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination The switching of surface envelope proteins expressed on the surface of pseudotype viruses enables them to be used as surrogate viruses in neutralization/antiviral screening assays and for the study of cell–virus receptor interactions. This day will discuss ongoing research, assay development and applications of the using pseudotype viruses for virus detection and vaccination.
Animal virus pseudotypes. Chair: Dr Simon Scott, University of Kent, UK
- Morning Poster Session: Human virus pseudotype
- Afternoon Poster Session: Animal virus pseudotypes.
The Next Generation of Vaccines, Adjuvants, and Delivery Systems: Lessons from the Past 50 Years
Dr Lawrence Dean Frenkel, Professor, Departments of Pediatrics and Microbiology, University of Illinois, USA
The state of HIV-1 co-infection
The introductory talk will briefly outline current understanding of major HIV-1 co-infections.
Mr Christopher Ward, PhD Student,Innate Immune Sensors Group, Institute of Infection & Immunity, Cardiff University School of Medicine, University Hospital of Wales
Optimizing delivery of next generation immune potentiators
Dr Manmohan Singh, Novartis Vaccines, North Carolina, USA
DNA Vaccination Encoding CD40 Targeted to Dendritic Cells Protects Against Chronic Kidney Disease.
Dr Yuan Min Wang, Senior Scientist, Senior Lecturer, University of Sydney Renal Laboratory, Centre for Kidney Research, Australia